Posted by Dakewlest > 2019-03-21 18:49 | Report Abuse

Moving up. Any TP, anyone?

Posted by keyin > 2019-03-21 19:15 | Report Abuse

Tp3

Posted by kmwong8711 > 2019-03-21 19:59 | Report Abuse

For me above 1.30 is good

Posted by k3nthiew > 2019-03-22 09:05 | Report Abuse

go! go! go!

Posted by k3nthiew > 2019-03-22 09:05 | Report Abuse

Getting contract soon?

Posted by Investeye > 2019-03-22 09:41 | Report Abuse

TA Research - 22 Mar 2019 Valuation & Recommendation :
We maintain Buy on Duopharma with a higher TP of RM1.61/share (previously RM1.52/share) based on unchanged 20.0x CY19 PER. We continue to like Duopharma for its: i) strong market share in Malaysia, and ii) move into niche pharmaceuticals products.

Posted by yapchehhak > 2019-03-26 01:05 | Report Abuse

https://www.theedgemarkets.com/article/insulin-epo-new-products-expected-boost-duopharma-fy19-earnings

Posted by k3nthiew > 2019-03-28 16:20 | Report Abuse

Push harder please....

Posted by yapchehhak > 2019-03-29 07:31 | Report Abuse

Slow and steady win the race

Posted by chshzhd > 2019-03-29 12:35 | Report Abuse

good counter,keep for long term..

Posted by Manekineko > 2019-04-03 16:38 | Report Abuse

Agree, waiting for next entry point when drop.

Posted by Dakewlest > 2019-04-04 10:30 | Report Abuse

Any idea for next entry point?

Posted by Dakewlest > 2019-04-08 10:34 | Report Abuse

Anyone know when are we getting the 4sen dividend?

Posted by chshzhd > 2019-04-08 11:05 | Report Abuse

last year div ex june

Posted by Heavenly PUNTER > 2019-04-08 21:35 | Report Abuse

Punter thinking this counter not bad too

Posted by Dakewlest > 2019-04-10 15:50 | Report Abuse

I bought some this week... may add some more later.

Posted by Investeye > 2019-04-10 16:54 | Report Abuse

Disposed some to take profit..

Posted by Investeye > 2019-04-23 09:56 | Report Abuse

Disposed most of the lots as EPF is gradually disposed this counter..
Wait for next wave..

Posted by Dakewlest > 2019-04-23 12:28 | Report Abuse

Epf acquired last week.

Posted by Investeye > 2019-04-23 16:40 | Report Abuse

Disposed all DPharma and bank on Pharma. In general, EPF disposed more than acquired..

Posted by keyin > 2019-04-23 17:37 | Report Abuse

Why EPF do so

Posted by VinLol123 > 2019-04-27 15:31 | Report Abuse

This counter suitable for long term..

Posted by YAPSS > 2019-05-25 09:28 | Report Abuse

Day 81 of Fundamental Daily, YAPSS will be covering Duopharma Biotech Berhad's fundamental via a short animated video. I hope it helps and please enjoy the video, see ya! #YAPSS #FundamentalDaily #DuopharmaBiotechBerhad

Click the on the link to find out more: https://youtu.be/wKtLhzvZy_c

Posted by moneytrail > 2019-06-22 18:39 | Report Abuse

Going for DRP and hold long term! Healthy sales!

Posted by Ern Siah > 2019-06-26 00:41 | Report Abuse

How to do the reinvestment?

Posted by NewbieTradingChannel > 2019-07-07 13:25 | Report Abuse

Dpharma 7/7/2019 now it is on a symmetrical triangle ... breaking 1.3900 can target 1.440.

Posted by Jason > 2019-08-01 16:22 | Report Abuse

bullish engulfing with volume, show time?

Posted by k3nthiew > 2019-08-06 16:11 | Report Abuse

https://www.reuters.com/article/us-duopharma-btech-malaysia/malaysias-duopharma-talks-deals-with-trade-war-hit-chinese-firms-idUSKCN1UW0E4

Posted by k3nthiew > 2019-08-06 16:12 | Report Abuse

KUALA LUMPUR (Reuters) - Duopharma Biotech (DUOP.KL), Malaysia’s largest generic drugmaker, is in talks with two Chinese consumer healthcare companies for expansion of their production base in Southeast Asia and a potential stake sale, its managing director said.

During an interview with Reuters, Duopharma Managing Director Leonard Ariff bin Abdul Shatar declined to name the companies as the discussions were ongoing. However, he said both “reasonably big” companies were listed in China with an annual revenue of more than $1 billion each.

The Chinese companies, one based in Shanghai and the other in Beijing, had asked Kuala Lumpur’s Duopharma if it would be able to contract-manufacture for them. They have also discussed buying a stake in Duopharma, Leonard said.

“They have manufacturing bases currently in China, supplying to the United States. These are guys whom I would not have expected to see in this part of the world, but for the trade war,” he said.

Duopharma, which has a market valuation of about $220 million, was open to a stake sale of up to 10% in the company, Leonard said, adding that if a deal was finalised, the Malaysian firm will apply to register with the U.S. Food and Drug Administration.

“There is a famous Malay saying: when two elephants fight, the ants die. But what we see here is absolutely the opposite. This has come as a bit of a surprise,” he said.

Dented by higher U.S. tariffs, Chinese companies are seeking partners to partly shift their supply chain to Southeast Asian countries such as Vietnam, Malaysia and Indonesia, analysts and Malaysian government officials said.

In the first quarter of 2019, Southeast Asia’s third-biggest economy attracted foreign investment of more than $7 billion – a 73% surge from a year earlier. The Malaysian government and its trade agencies are sending their representatives to China and other countries, organizing seminars and signing agreements of cooperation.

Late last month, the China ambassador to Malaysia confirmed the high level of Chinese interest in its traditional trade partner.

Posted by Coldman > 2019-08-06 16:50 | Report Abuse

Very good news for stakeholder, hope it can be deal soon.

Posted by Jason > 2019-08-06 17:20 | Report Abuse

Good fundamental and aggressive management. This counter is worth to hold for long term investment.

Posted by moneytrail > 2019-08-07 23:04 | Report Abuse

No action yet. So difficult to bull doze pass 1.43. :(

Posted by Jason > 2019-08-08 09:36 | Report Abuse

1.43 been tested many times. Damn hard to breach.

Posted by Shootup > 2019-08-09 06:19 | Report Abuse

what so good it is, gotta share profit out after the deal

Posted by Jason > 2019-08-21 17:07 | Report Abuse

what happens to dpharma today?

Posted by kalofarmako > 2019-08-22 15:37 | Report Abuse

Hello

Posted by Jason > 2019-08-22 16:25 | Report Abuse

hope it can break the strong resistance at 1.43.

Posted by Jason > 2019-08-23 14:56 | Report Abuse

finally it moves after consolidate for so long

Posted by Shootup > 2019-08-23 15:14 | Report Abuse

All time high qr must be good

Posted by kalofarmako > 2019-08-26 10:45 | Report Abuse

yeahh. i can see the movement there.

Posted by kalofarmako > 2019-08-26 10:52 | Report Abuse

It's going up time to buy ! Come on gaiss.

https://klse.i3investor.com/blogs/MYpharmaceuticalnews/221505.jsp

Posted by Jason > 2019-08-27 23:12 | Report Abuse

quiet counter

Posted by kalofarmako > 2019-08-28 09:55 | Report Abuse

Quiet but the price still okay hoo

Posted by kalofarmako > 2019-08-28 09:59 | Report Abuse

Pharmaniaga’s focus on non-concession ops seen to boost profit

https://www.klsescreener.com/v2/news/view/572140

Posted by Jason > 2019-08-28 11:54 | Report Abuse

among all the other healthcare counter, only this one is on uptrend. Phamaniage revenue and profit is inconsistent and poor cash flow, no way to compare to duopharma.

Posted by Jason > 2019-08-29 16:07 | Report Abuse

dpharma rock today, achieving new high..

Posted by kalofarmako > 2019-08-30 09:10 | Report Abuse

Morning!

Something good to read in the morning.

"High time to decide on concession issue"

Read more: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/222426.jsp

Posted by Jason > 2019-09-03 21:00 | Report Abuse

boring dpharma

Posted by kalofarmako > 2019-09-05 13:09 | Report Abuse

WOW!!

The positive long-term outlook for Pharmaniaga

Read more: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/223457.jsp

Posted by kalofarmako > 2019-09-11 10:56 | Report Abuse

DHM explained that Pharmaniaga is only responsible for the logistics of supplying drugs to government health facilities, rather than the supply itself.

Check out here: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/224313.jsp